Trademark Overview
On Saturday, May 9, 2026, a trademark application was filed for HYBRID-ON with the United States Patent and Trademark Office. The USPTO has given the HYBRID-ON trademark a serial number of 99813264. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, May 9, 2026. This trademark is owned by ADVANCED RNA TECHNOLOGIES, LLC. The HYBRID-ON trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:
Scientific and medical research services, namely, development, validation, and performance of molecular and biochemical assays for detection, localization, and quantification of nucleic acid-based therapeutics and research-use nucleic acid compounds in biological samples and tissues for research, preclinical, nonclinical, and clinical study purposes in human and veterinary fields; bioanalytical testing services relating to pharmacokinetics, pharmacodynamics, biodistribution, toxicokinetics, and tissue exposure of nucleic acid–based compounds; laboratory analysis, evaluation, and reporting of data generated in connection with such studies; custom design and development of detection assays and related reagents for research use; assay validation services; scientific consultancy relating to assay development, bioanalytical strategies, and technology transfer in the field of nucleic acid–based therapeutics and research compounds; and licensing of scientific research assay technology
Chemical and biochemical reagents for scientific and medical research use, namely, nucleic acid probes, nucleic acids detection reagents, assay buffers, and diagnostic assay kits comprised primarily of reagents for detection, localization, and quantification of nucleic acid-based therapeutics and research-use nucleic acid compounds in biological samples and tissues, all for research use only in human and veterinary fields
